oxycodonhydrochlorid "g.l." 5 mg filmovertrukne tabletter
g.l. pharma gmbh - oxycodonhydrochlorid - filmovertrukne tabletter - 5 mg
paricalcitol "pharmathen" 2 mikrogram/ml injektionsvæske, opløsning
pharmathen s.a. - paricalcitol - injektionsvæske, opløsning - 2 mikrogram/ml
paricalcitol "pharmathen" 5 mikrogram/ml injektionsvæske, opløsning
pharmathen s.a. - paricalcitol - injektionsvæske, opløsning - 5 mikrogram/ml
anagrelid "aop" 0,5 mg kapsler, hårde
aop orphan pharmaceuticals gmbh - anagrelidhydrochlorid - kapsler, hårde - 0,5 mg
atosiban "ever pharma" 6,75 mg/0,9 ml injektionsvæske, opløsning
ever valinject gmbh - atosiban - injektionsvæske, opløsning - 6,75 mg/0,9 ml
atosiban "ever pharma" 37,5 mg/5 ml koncentrat til infusionsvæske, opløsning
ever valinject gmbh - atosiban - koncentrat til infusionsvæske, opløsning - 37,5 mg/5 ml
klomentan 100 mg filmovertrukne tabletter
aristo pharma gmbh - losartankalium - filmovertrukne tabletter - 100 mg
tibolon "aristo" 2,5 mg tabletter
aristo pharma gmbh - tibolon - tabletter - 2,5 mg
oxycodone "hameln" 10 mg/ml injektions-/infusionsvæske, opløsning
hameln pharma gmbh - oxycodonhydrochlorid - injektions-/infusionsvæske, opløsning - 10 mg/ml
ribavirin teva pharma b.v.
teva b.v. - ribavirin - hepatitis c kronisk - antivirale midler til systemisk anvendelse - ribavirin teva pharma b. is indicated in combination with other medicinal products for the treatment ofchronic hepatitis c (chc) in adults (see sections 4. 2, 4. 4 og 5. ribavirin teva pharma b. is indicated in combination with other medicinal products for the treatment ofchronic hepatitis c (chc) for paediatric patients (children 3 years of age and older and adolescents) notpreviously treated and without liver decompensation (see sections 4. 2, 4. 4 og 5.